PLoS ONE (Jan 2016)

miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.

  • Violaine Tribollet,
  • Bruno Barenton,
  • Auriane Kroiss,
  • Séverine Vincent,
  • Ling Zhang,
  • Christelle Forcet,
  • Catherine Cerutti,
  • Séverine Périan,
  • Nathalie Allioli,
  • Jacques Samarut,
  • Jean-Marc Vanacker

DOI
https://doi.org/10.1371/journal.pone.0156445
Journal volume & issue
Vol. 11, no. 5
p. e0156445

Abstract

Read online

MicroRNA-135a (miR-135a) down-modulates parameters of cancer progression and its expression is decreased in metastatic breast cancers (as compared to non-metastatic tumors) as well as in prostate tumors relative to normal tissue. These expression and activity patterns are opposite to those of the Estrogen-Related Receptor α (ERRα), an orphan member of the nuclear receptor family. Indeed high expression of ERRα correlates with poor prognosis in breast and prostate cancers, and the receptor promotes various traits of cancer aggressiveness including cell invasion. Here we show that miR-135a down-regulates the expression of ERRα through specific sequences of its 3'UTR. As a consequence miR-135a also reduces the expression of downstream targets of ERRα. miR-135a also decreases cell invasive potential in an ERRα-dependent manner. Our results suggest that the decreased expression of miR-135a in metastatic tumors leads to elevated ERRα expression, resulting in increased cell invasion capacities.